Mobile Menu

Genomics week in brief: Week ending 20th March

Check out our latest Genomics week in brief – jam-packed with all the latest genomics news and research, all in one place!

Top stories from the past week

  • New study demonstrates how certain proteins alter the architecture of the X chromosome, which ultimately contribute to its inactivation. (Kriz et al, 2021)
  • Renal fibrosis leads to kidney failure and can only be treated by dialysis. Now, researchers are seeking to treat renal fibrosis by acting on telomere shortening – demonstrating that short telomeres are at the origin of this disease. (Blasco et al, 2021)
  • Researchers have found an epigenetic mechanism that is contributing to lifelong stress susceptibility, and can be reversed in animal models using a small-molecule inhibitor. (Nestler et al, 2021)
  • A recent study has investigated circulating small noncoding RNAs in Parkinson’s disease patients, revealing hallmarks and regulatory modules of the transcriptome involved during disease progression. (Keller et al, 2021)
  • According to a new study, a high tumour mutational burden is only useful for predicting clinical responses to immune checkpoint inhibitors in a subset of cancer types. (Lin et al, 2021)
  • A new research paper has shown a clear advantage of the use of genetic testing in helping healthcare providers choose the appropriate anti-platelet drug. (Pereira et al, 2021)
  • Researchers from Stanford University have developed a new technique that has enabled them to discover new genetic differences between humans and chimpanzees. (Fraser et al, 2021)
  • Scientists have identified and characterised two regions of DNA that are required for the proper expression of Mecp2/MECP2 in mice and humans. (Zoghbi et al, 2021)
  • A UCLA-led research team has identified a chemical cocktail that enables the production of large numbers of muscle stem cells. These stem cells can self-renew and give rise to all types of skeletal muscle cells. (Li et al, 2021)
  • New research led by Baylor College of Medicine has explored how rare genetic variants contribute to increased risk of lung cancer. (Amos et al, 2021)

In other news

  • Jessica Richman and Zachary Apte, co-founders of uBiome Inc., were charged last week with defrauding investors out of $60 million by falsely portraying uBiome as a successful start-up. (SEC, 2021)


  • Join us for the final webinar in our brand-new webinar series – ‘Next-Gen PCR ONLINE’. The webinar is taking place on Thursday 25th March at 3PM GMT/4PM CET/11AM EDT. In this series, we highlight how next-gen PCR methods can impact modern science. Register now.
  • Make sure you catch up on our latest webinar series – ‘Microbiome Sequencing ONLINE‘. In this series, we explored how metagenomics and microbiome sequencing is uncovering the hidden traits of the invisible world. To watch the webinars on-demand register now.


  • Delve into all things liquid biopsy with our latest report: ‘Liquid Biopsy: Current Status and Future Directions’. This report will provide you with an overview of liquid biopsy technologies, exclusive interviews with key leaders in the field and insights into the current technical and social barriers impacting clinical uptake. Download your free copy here.
  • Optimising sample isolation and preparation is important to ensure that the quality of your sequencing output is not compromised. Check out our report: ‘Sample Preparation Guide for MPS’ which covers everything you need to know about sample preparation. Download your free copy here
  • Download our latest ‘Sequencing Buyer’s Guide’. This guide will help you understand the sequencing landscape as well as make better purchasing decision. You can download the guide for free here.

More on these topics

Genomics / Week in brief

Share this article